Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cancer
MedTech
Grail sees Q3 sales jump, eyes Q1 for FDA Galleri PMA submission
Grail saw a sharp rise in third-quarter sales as it outlined a firmer FDA submission date for its Galleri cancer blood test.
Ben Adams
Nov 13, 2025 9:05am
ESMO: Pfizer sees year-long weight gain in cancer patients
Oct 17, 2025 12:45pm
Boehringer digs in on ADCs with $991M AimedBio licensing accord
Oct 15, 2025 10:05am
Tubulis touts $361M series C as next-gen ADC data drop nears
Oct 15, 2025 5:01am
Exact Sciences rolls out Cancerguard multi-cancer blood test
Sep 11, 2025 1:00pm
Investor syndicate takes majority stake in HistoSonics
Aug 7, 2025 1:16pm
